Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis. [electronic resource]
Producer: 20151124Description: 1640-9 p. digitalISSN:- 1462-0332
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- blood
- Biomarkers -- blood
- Cost-Benefit Analysis
- Decision Support Techniques
- Disability Evaluation
- Disease Management
- Health Care Costs
- Hematologic Tests -- economics
- Humans
- Outcome Assessment, Health Care
- Prognosis
- Quality-Adjusted Life Years
- Sensitivity and Specificity
- Severity of Illness Index
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.